IL91047A - Zinc complexes for the treatment of free radical- induced diseases - Google Patents

Zinc complexes for the treatment of free radical- induced diseases

Info

Publication number
IL91047A
IL91047A IL91047A IL9104789A IL91047A IL 91047 A IL91047 A IL 91047A IL 91047 A IL91047 A IL 91047A IL 9104789 A IL9104789 A IL 9104789A IL 91047 A IL91047 A IL 91047A
Authority
IL
Israel
Prior art keywords
treatment
free radical
zinc complexes
induced diseases
zinc
Prior art date
Application number
IL91047A
Other languages
English (en)
Other versions
IL91047A0 (en
Inventor
Chevion Mordechai
Original Assignee
Yissum Res Dev Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yissum Res Dev Co filed Critical Yissum Res Dev Co
Priority to IL91047A priority Critical patent/IL91047A/xx
Publication of IL91047A0 publication Critical patent/IL91047A0/xx
Priority to DE69006654T priority patent/DE69006654T2/de
Priority to AT90307400T priority patent/ATE101594T1/de
Priority to ES90307400T priority patent/ES2062375T3/es
Priority to EP90307400A priority patent/EP0409452B1/en
Priority to US07/550,462 priority patent/US5075469A/en
Publication of IL91047A publication Critical patent/IL91047A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Paper (AREA)
IL91047A 1989-07-19 1989-07-19 Zinc complexes for the treatment of free radical- induced diseases IL91047A (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
IL91047A IL91047A (en) 1989-07-19 1989-07-19 Zinc complexes for the treatment of free radical- induced diseases
DE69006654T DE69006654T2 (de) 1989-07-19 1990-07-06 Einen Zink-Komplex enthaltende Arzneimittel.
AT90307400T ATE101594T1 (de) 1989-07-19 1990-07-06 Einen zink-komplex enthaltende arzneimittel.
ES90307400T ES2062375T3 (es) 1989-07-19 1990-07-06 Composiciones farmaceuticas que contienen un complejo de zinc.
EP90307400A EP0409452B1 (en) 1989-07-19 1990-07-06 Pharmaceutical compositions containing a zinc complex
US07/550,462 US5075469A (en) 1989-07-19 1990-07-10 Pharmaceutical compositions containing a zinc complex

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL91047A IL91047A (en) 1989-07-19 1989-07-19 Zinc complexes for the treatment of free radical- induced diseases

Publications (2)

Publication Number Publication Date
IL91047A0 IL91047A0 (en) 1990-02-09
IL91047A true IL91047A (en) 1993-06-10

Family

ID=11060194

Family Applications (1)

Application Number Title Priority Date Filing Date
IL91047A IL91047A (en) 1989-07-19 1989-07-19 Zinc complexes for the treatment of free radical- induced diseases

Country Status (6)

Country Link
US (1) US5075469A (xx)
EP (1) EP0409452B1 (xx)
AT (1) ATE101594T1 (xx)
DE (1) DE69006654T2 (xx)
ES (1) ES2062375T3 (xx)
IL (1) IL91047A (xx)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX12394A (es) * 1987-07-23 1993-12-01 Ciba Geigy Ag Procedimiento par la obtencion de carbamatos de polietilenglicol.
IL106064A (en) * 1993-06-18 1997-11-20 Yissum Res Dev Co Gallium complexes for the treatment of free radical-induced diseases
US5637311A (en) * 1995-06-29 1997-06-10 Procyte Corporation Zinc(II) complexes and methods related thereto
US6140305A (en) * 1996-04-04 2000-10-31 Bio-Rad Laboratories, Inc. Hereditary hemochromatosis gene products
US7026116B1 (en) 1996-04-04 2006-04-11 Bio-Rad Laboratories, Inc. Polymorphisms in the region of the human hemochromatosis gene
US6849399B1 (en) 1996-05-23 2005-02-01 Bio-Rad Laboratories, Inc. Methods and compositions for diagnosis and treatment of iron misregulation diseases
AU745403B2 (en) 1997-06-13 2002-03-21 Bio-Rad Laboratories, Inc. Methods and compositions for diagnosis and treatment of iron overload diseases and iron deficiency diseases
AU2006337161B2 (en) 2006-02-03 2012-06-07 Obagi Cosmeceuticals Llc Anti-aging treatment using copper and zinc compositions
US7897800B2 (en) 2006-02-03 2011-03-01 Jr Chem, Llc Chemical compositions and methods of making them
US7687650B2 (en) 2006-02-03 2010-03-30 Jr Chem, Llc Chemical compositions and methods of making them
US7867522B2 (en) 2006-09-28 2011-01-11 Jr Chem, Llc Method of wound/burn healing using copper-zinc compositions
US8273791B2 (en) 2008-01-04 2012-09-25 Jr Chem, Llc Compositions, kits and regimens for the treatment of skin, especially décolletage
WO2010085753A1 (en) 2009-01-23 2010-07-29 Jr Chem, Llc Rosacea treatments and kits for performing them
EP2467135B1 (en) * 2009-08-19 2017-02-01 Mordechai Chevion Desferrioxamine-metal complexes for the treatment of immune-related disorders
US8952057B2 (en) 2011-01-11 2015-02-10 Jr Chem, Llc Compositions for anorectal use and methods for treating anorectal disorders
WO2014197250A1 (en) 2013-06-06 2014-12-11 Amip, Llc Iron supplement
AU2015369552B2 (en) 2014-12-22 2020-11-19 Eduard Berenshtein New metal complexes of nocardamine and their use in pharmaceutical compositions
WO2017137988A1 (en) 2016-02-11 2017-08-17 Mordechai Chevion Method and pharmaceutical composition for treatment of neurodegeneration
CA3097313A1 (en) * 2018-04-15 2019-10-24 Mordechai Chevion Compositions and methods for treatment of iron overload

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2554690A (en) * 1944-06-13 1951-05-29 Squibb & Sons Inc Zinc-penicillin and preparation thereof
US3297531A (en) * 1963-12-11 1967-01-10 Ernst A H Friedheim Complexes of trivalent antimony with penicillamine, and admixtures of excess penicillamine with said complexes
ATE98631T1 (de) * 1988-01-20 1994-01-15 Ciba Geigy Ag Verfahren zur herstellung von komplexverbindungen.

Also Published As

Publication number Publication date
EP0409452A1 (en) 1991-01-23
ATE101594T1 (de) 1994-03-15
IL91047A0 (en) 1990-02-09
EP0409452B1 (en) 1994-02-16
DE69006654T2 (de) 1994-05-26
ES2062375T3 (es) 1994-12-16
US5075469A (en) 1991-12-24
DE69006654D1 (de) 1994-03-24

Similar Documents

Publication Publication Date Title
IL91047A (en) Zinc complexes for the treatment of free radical- induced diseases
TW224942B (xx)
TW376319B (en) Pharmaceutical composition containing risperidone pamoate and having a long acting activity for treating psychoses induced by the release of dopamine
HK1004257A1 (en) Use of droloxifene in the treatment of bone diseases
MX9206577A (es) COMPOSICIóN FARMACEUTICA PARA INHIBIR EL CRECIMIENTO DE CELULAS TUMORALES
IL106562A0 (en) Pharmaceutical and/or cosmetic compositions and the use thereof
TW234691B (xx)
GB9200417D0 (en) Cytotoxic drug therapy
EP0781561A4 (en) NEW MEDICAL USE OF A 5HT 3 ANTAGONIST?
EP0620004A4 (en) MEDICAL COMPOSITION.
EP0412554A3 (en) Sustained-release preparation for administration into brain
GR3022995T3 (en) Pharmaceutical composition consisting of flupirtin and morphine for the treatment of pain and to avoid a morphine addiction
EP0295695A3 (en) New pyrazoline derivatives and agents for treating cerebnew pyrazoline derivatives and agents for treating cerebrovascular diseases containing the same as active ingredrovascular diseases containing the same as active ingredient ient
DK0583026T3 (xx)
GR3018674T3 (en) Treatment of hepatobiliary disease with 15-keto-prostaglandin compounds
EP0495106A4 (en) Osteogenesis promoter
EP0430551A3 (en) Treatment of cardiac dysfunction with 15-keto-prostaglandin compounds
GR3022706T3 (en) Use of 15-dehydroxy-16-oxoprostaglandin derivatives in the treatment of allergic diseases
IL106289A (en) Phospholipid derivatives their preparation and pharmaceutical compositions containing them
EP0335446A3 (en) Agents for treating neoplasms
IL98200A0 (en) Pharmaceutical composition containing a derivative of substituted-l-valyl-l-prolinamide
IL106064A (en) Gallium complexes for the treatment of free radical-induced diseases
EP0127389A3 (en) N,n-diethyl-5-methyl-2h-1-benzothiopyrano-(4,3,2-cd)-indazole-2-ethanamine, compositions comprising the same and uses therefor
ATE89288T1 (de) L-pyroglutamyl-l-cystein-dipeptid mit hoher anti- cataractogener wirkung und dies enthaltende pharmazeutische zusammensetzungen.
ATE224716T1 (de) Pharmazeutische zusammensetzungen von cinchonin dihydrochlorid

Legal Events

Date Code Title Description
RH Patent void